PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.62%
Negative revenue growth while AVGO stands at 2.83%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-2.43%
Negative gross profit growth while AVGO is at 4.82%. Joel Greenblatt would examine cost competitiveness or demand decline.
-7.22%
Negative EBIT growth while AVGO is at 33.22%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-7.22%
Negative operating income growth while AVGO is at 33.22%. Joel Greenblatt would press for urgent turnaround measures.
-7.08%
Negative net income growth while AVGO stands at 160.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-7.69%
Negative EPS growth while AVGO is at 164.15%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-4.76%
Negative diluted EPS growth while AVGO is at 160.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.65%
Share reduction while AVGO is at 0.39%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.20%
Reduced diluted shares while AVGO is at 2.21%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-1.68%
Dividend reduction while AVGO stands at 9.45%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-62.31%
Negative OCF growth while AVGO is at 26.25%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-63.52%
Negative FCF growth while AVGO is at 66.15%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
107.11%
10Y revenue/share CAGR under 50% of AVGO's 272.86%. Michael Burry would suspect a lasting competitive disadvantage.
61.04%
5Y revenue/share CAGR under 50% of AVGO's 231.84%. Michael Burry would suspect a significant competitive gap or product weakness.
21.95%
3Y revenue/share CAGR under 50% of AVGO's 179.02%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
117.69%
10Y OCF/share CAGR under 50% of AVGO's 10191.57%. Michael Burry would worry about a persistent underperformance in cash creation.
3.07%
Below 50% of AVGO's 985.76%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-6.70%
Negative 3Y OCF/share CAGR while AVGO stands at 232.47%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
466.73%
Below 50% of AVGO's 4809.41%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
165.77%
Below 50% of AVGO's 754.86%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
7.41%
Below 50% of AVGO's 169.79%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
240.03%
Equity/share CAGR of 240.03% while AVGO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
74.30%
Below 50% of AVGO's 208.89%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
28.58%
Below 50% of AVGO's 70.87%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-7.02%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
1.42%
We show growth while AVGO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-5.33%
Negative asset growth while AVGO invests at 1.96%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-4.92%
We have a declining book value while AVGO shows 11.43%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
0.44%
We have some new debt while AVGO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-0.71%
Our R&D shrinks while AVGO invests at 0.43%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
2.51%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.